Literature DB >> 20146589

Role of PET/CT imaging in stereotactic body radiotherapy.

Malolan S Rajagopalan1, Dwight E Heron.   

Abstract

Stereotactic body radiotherapy (SBRT) is a relatively new technique that enables delivery of high doses of radiation to malignancies throughout the body with a higher degree of precision than conventional radiation modalities. PET and computed tomography are rapidly being adopted for the evaluation of patients with cancer, and its role in conjunction with SBRT is under active investigation. This article reviews the literature regarding the utility of PET and computed tomography in treatment planning, follow-up imaging, relationship with clinical outcomes, and other topics in patients treated with SBRT. These questions are investigated for cancers of the lung, head and neck, pancreas and liver. A brief overview of various commercially available SBRT treatment systems is also included.

Entities:  

Mesh:

Year:  2010        PMID: 20146589     DOI: 10.2217/fon.09.166

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

Review 1.  Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

Authors:  Percy Lee; Billy W Loo; Tithi Biswas; George X Ding; Issam M El Naqa; Andrew Jackson; Feng-Ming Kong; Tamara LaCouture; Moyed Miften; Timothy Solberg; Wolfgang A Tome; An Tai; Ellen Yorke; X Allen Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-05       Impact factor: 8.013

2.  Long-Term Tumor Control despite Late Pseudoprogression on(18)F-FDG-PET following Extremely Hypofractionated Stereotactic Radiotherapy for Retropharyngeal Lymph Node Metastasis from Esthesioneuroblastoma.

Authors:  Kazuhiro Ohtakara; Hiroaki Hoshi
Journal:  Case Rep Oncol       Date:  2014-08-18

Review 3.  Evaluation of tumor response after stereotactic body radiation therapy for lung cancer: Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Pino Alcantara; Beatriz Cabeza Martínez; Marta García García-Esquinas; Laura G Belaústegui; Ana Bustos
Journal:  J Clin Transl Res       Date:  2020-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.